BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 8296189)

  • 1. [Chronic myeloid leukemia. State of the art, May 1993].
    Hehlmann R
    Schweiz Med Wochenschr; 1994 Jan; 124(1-2):37-43. PubMed ID: 8296189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The assessment of therapeutic success in chronic myeloid leukemia].
    Griesshammer M; Hehlmann R; Heimpel H
    Dtsch Med Wochenschr; 1995 Apr; 120(17):620-5. PubMed ID: 7537652
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic myelogenous leukemia: state of the art.
    Polli EE; Pozzoli E; Annaloro C
    Ann Ital Med Int; 1991; 6(4 Pt 2):491-7. PubMed ID: 1840816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of bcr-abl mRNA in single progenitor colonies from patients with chronic myeloid leukemia by PCR: comparison with cytogenetics and PCR from uncultured cells.
    Schulze E; Krahl R; Thalmeier K; Helbig W
    Exp Hematol; 1995 Dec; 23(14):1649-54. PubMed ID: 8542960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approaches to the treatment of chronic myeloid leukemia.
    Savage DG; Goldman JM
    Int J Hematol; 1994 Jul; 60(1):1-21. PubMed ID: 7919235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic myeloid leukemia--latest aspects and practical progress in recent years].
    Griesshammer M; Heimpel H
    Med Klin (Munich); 1995 Sep; 90(9):527-31. PubMed ID: 7476731
    [No Abstract]   [Full Text] [Related]  

  • 7. Current controversies on the role of interferon-alpha for therapy of chronic myeloid leukemia.
    Heimpel H; Allan NC; Baccarani M; Guilhot F; Hehlmann R; Horowitz M; Kluin-Nelemans J; Schaefer U; Storb R; Thaler J
    Bone Marrow Transplant; 1996 May; 17 Suppl 3():S39. PubMed ID: 8769699
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chronic myeloid leukemia].
    Hehlmann R
    Ther Umsch; 1996 Feb; 53(2):82-7. PubMed ID: 8629268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on therapy for chronic myelogenous leukemia.
    Weinberger BB
    J La State Med Soc; 1994 Aug; 146(8):341-3. PubMed ID: 7930864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
    Ohnishi K; Minami S; Ueda T; Nishimura M; Tsubaki K; Takemoto Y; Takeshita A; Sao H; Kageyama S; Ueda R; Ohno R
    Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic myeloid leukemia: progress and prospects].
    Baccarani M; Russo D; Fanin R
    Haematologica; 1991 Jun; 76 Suppl 3():40-5. PubMed ID: 1752539
    [No Abstract]   [Full Text] [Related]  

  • 13. e6a2 BCR-ABL transcript in chronic myeloid leukemia: is it associated with aggressive disease?
    Colla S; Sammarelli G; Voltolini S; Crugnola M; Sebastio P; Giuliani N
    Haematologica; 2004 May; 89(5):611-3. PubMed ID: 15136228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic myelogenous leukemia: progress in chemotherapy and evaluation of prognostic score 1. The German CML Study Group.
    Hehlmann R; Ansari H; Hasford J; Heimpel H
    Semin Hematol; 1993 Jul; 30(3 Suppl 3):44-8. PubMed ID: 8235707
    [No Abstract]   [Full Text] [Related]  

  • 15. Polymerase chain reaction is highly predictive of relapse in patients following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Mackinnon S; Barnett L; Heller G
    Bone Marrow Transplant; 1996 Apr; 17(4):643-7. PubMed ID: 8722369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of interferon-alpha on the prognosis of bone marrow transplantation in chronic myeloid leukemia].
    Xu L; Guo N; Huang X
    Zhonghua Xue Ye Xue Za Zhi; 2001 Nov; 22(11):589-91. PubMed ID: 11855148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytogenetic analysis and bcr/abl mRNA detection in chronic myeloid leukemia].
    Yao B; Guo M; Pian H
    Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):137-9. PubMed ID: 11601240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal residual disease in chronic myeloid leukaemia.
    Cross NC
    Hematol Cell Ther; 1998 Oct; 40(5):224-8. PubMed ID: 9844816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interferon-alpha in the treatment of chronic myeloid leukemia].
    Guilhot F
    Rev Prat; 1999 Mar; 49(5):464-6. PubMed ID: 10358394
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic significance of genetic markers in chronic myelogenous leukemia patients after bone marrow transplantation.
    Zámecníková A; Kri an P; Mistrík M
    Neoplasma; 2000; 47(5):299-302. PubMed ID: 11130247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.